Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden
· Delayed Price · Currency is SEK 3.170
+0.370 (13.21%)
At close: Mar 6, 2026
Bio-Works Technologies AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 62.5 | 25.47 | 43.9 | 41.32 | 21.91 | Upgrade
|
| Other Revenue | 0.61 | 5.02 | - | - | 34.45 | Upgrade
|
| Revenue | 63.11 | 30.49 | 43.9 | 41.32 | 56.36 | Upgrade
|
| Revenue Growth (YoY) | 107.01% | -30.55% | 6.23% | -26.68% | 679.09% | Upgrade
|
| Cost of Revenue | 14.7 | 5.45 | 17.08 | 12.47 | 3.35 | Upgrade
|
| Gross Profit | 48.41 | 25.04 | 26.82 | 28.85 | 53.01 | Upgrade
|
| Selling, General & Admin | 64.22 | 60.2 | 81.63 | 74.95 | 62.5 | Upgrade
|
| Other Operating Expenses | 1.2 | 0.12 | 2.09 | 0.57 | 0.76 | Upgrade
|
| Operating Expenses | 65.93 | 60.83 | 84.33 | 75.99 | 63.97 | Upgrade
|
| Operating Income | -17.52 | -35.8 | -57.5 | -47.14 | -10.96 | Upgrade
|
| Interest Expense | -0.19 | -0.01 | -0 | -0.02 | -0.02 | Upgrade
|
| Interest & Investment Income | 0.55 | 0.6 | 0.88 | 0.35 | 0.07 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.93 | 1.89 | 2.12 | 1.53 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | - | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | -17.16 | -34.28 | -54.73 | -44.7 | -9.37 | Upgrade
|
| Merger & Restructuring Charges | - | -3 | - | - | - | Upgrade
|
| Pretax Income | -17.16 | -37.28 | -54.73 | -44.7 | -9.37 | Upgrade
|
| Income Tax Expense | -1.92 | 0.08 | 2.09 | 0.26 | 3.57 | Upgrade
|
| Net Income | -15.25 | -37.36 | -56.82 | -44.95 | -12.94 | Upgrade
|
| Net Income to Common | -15.25 | -37.36 | -56.82 | -44.95 | -12.94 | Upgrade
|
| Shares Outstanding (Basic) | 83 | 50 | 36 | 35 | 31 | Upgrade
|
| Shares Outstanding (Diluted) | 83 | 50 | 36 | 35 | 31 | Upgrade
|
| Shares Change (YoY) | 65.69% | 38.31% | 3.16% | 12.17% | 2.60% | Upgrade
|
| EPS (Basic) | -0.18 | -0.75 | -1.57 | -1.28 | -0.41 | Upgrade
|
| EPS (Diluted) | -0.18 | -0.75 | -1.57 | -1.28 | -0.41 | Upgrade
|
| Free Cash Flow | -19.22 | -43.18 | -59.85 | -41 | -14.31 | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -0.86 | -1.66 | -1.17 | -0.46 | Upgrade
|
| Gross Margin | 76.70% | 82.13% | 61.10% | 69.81% | 94.06% | Upgrade
|
| Operating Margin | -27.76% | -117.42% | -131.00% | -114.09% | -19.44% | Upgrade
|
| Profit Margin | -24.16% | -122.54% | -129.45% | -108.78% | -22.96% | Upgrade
|
| Free Cash Flow Margin | -30.45% | -141.63% | -136.34% | -99.23% | -25.39% | Upgrade
|
| EBITDA | -17.01 | -35.28 | -56.89 | -46.67 | -10.47 | Upgrade
|
| EBITDA Margin | -26.95% | -115.73% | -129.61% | -112.95% | -18.57% | Upgrade
|
| D&A For EBITDA | 0.51 | 0.51 | 0.61 | 0.47 | 0.49 | Upgrade
|
| EBIT | -17.52 | -35.8 | -57.5 | -47.14 | -10.96 | Upgrade
|
| EBIT Margin | -27.76% | -117.41% | -131.00% | -114.09% | -19.44% | Upgrade
|
| Revenue as Reported | 62.91 | 32.94 | 46.7 | 43.01 | 58.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.